Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

RACE-2L: Real-World Assessment of Clinical Practice and Outcomes in Non-squamous Non-Small Cell Lung Cancer After Failure of Platinum-based Chemotherapy in Brazil

NCT06491862 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT06491862
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06491862 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
RACE-2L: Real-World Assessment of Clinical Practice and Outcomes in Non-squamous Non-Small Cell Lung Cancer After Failure of Platinum-based Chemotherapy in Brazil
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Recruiting
Start date
July 25, 2024
Completion date
December 31, 2026
Enrollment
250 (estimated)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

non-squamous non-small cell lung cancer